DIA

Providing Online Education Programs for Drug Development Professionals

Drug Information Association (DIA), a global professional member association, and UL have announced a new strategic alliance to create online educational offerings for biotechnology, pharmaceutical, academic and regulatory professionals around the world. The DIA addresses solutions to issues and challenges involved in the discovery, development, and lifecycle management of pharmaceuticals, medical devices, and related products. DIA members will now have access to UL’s online compliance solutions used by over one million individuals in more than 50 countries.

Under the agreement, UL and DIA have created a solution that addresses the discovery, development and life cycle management training objectives of DIA’s constituents. Key topics range from:

• Good Clinical Practices (GCP)
• Selecting and Managing Contract Research Organizations (CROs)
• Bioresearch Monitoring
• Drug and Medical Device Safety and Adverse Event Reporting
• Good Manufacturing Practices (GMP)
• Change Control
• Process Validation

In the future, the solution will include new content emerging from DIA’s select training courses.

DIA (www.diahome.org) is a neutral, global, professional, member-driven association of nearly 18,000 biotechnology, pharmaceutical, academic, and regulatory professionals. Through our international educational offerings and myriad networking opportunities, DIA provides a global forum for knowledge exchange that fosters the innovation of products, technologies, and services to improve health and well-being worldwide. Headquarters are in Horsham, PA, USA, with offices in Basel, Switzerland, Tokyo, Japan, Mumbai, India, and Beijing, China.